Maxim Group Downgrades BioRestorative Therapies to Hold

Maxim Group analyst Michael Okunewitch has downgraded BioRestorative Therapies (NASDAQ: BRTX) from a 'Buy' rating to 'Hold'. This change reflects a shift in the analyst's outlook on the company's stock performance.